Rezolute, INC Form 4 insider transactions

Handok, Inc., a director and 10% owner of Rezolute, Inc., reports changes in beneficial ownership of common shares through open market transactions.

Rezolute, Inc. CFO Daron Evans reports purchasing 20,000 shares of common stock at an average price of $1.6915 on March 15, 2024.

Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., reports the acquisition of 10,000 common shares at $1.88 per share on March 14, 2024.

Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., files an amended Form 4 to correct the reported indirect holdings of common shares held by his minor child.

Director Kim Young-Jin reports purchasing additional shares of Rezolute, Inc.

Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., reports purchasing 500 shares of common stock at $1.85 per share on March 7, 2024.

Daron Evans, CFO of Rezolute, Inc., recently purchased 50,000 common shares of the company at an average price of $1.9269.

Rezolute, Inc. CEO Nevan C. Elam purchased 5,000 shares of the company's common stock at a price of $1.68 per share on February 26, 2024.

Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., reports purchasing shares of the company's common stock in two transactions.